PCS-话题@MedSci - 梅斯（MedSci）

#PCS#

107篇内容 | 3252人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1685562, encodeId=24e61685562ec, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=郭艺芳：PCSK9单克隆抗体能否撼动他汀霸主地位？, objectType=article, longId=32846, objectId=95f2328469f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95f2328469f, replyNumber=0, likeNumber=102, createdTime=2014-08-26, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95f2328469f, moduleTitle=郭艺芳：PCSK9单克隆抗体能否撼动他汀霸主地位？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=95f2328469f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685554, encodeId=2c9e1685554af, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=SHPCS 2013：胰腺癌的外科治疗——R0切除, objectType=article, longId=23282, objectId=c0e82328236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e82328236, replyNumber=0, likeNumber=63, createdTime=2013-12-30, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e82328236, moduleTitle=SHPCS 2013：胰腺癌的外科治疗——R0切除, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c0e82328236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685560, encodeId=b125168556054, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=ACC 2014：PCSK9抑制剂显著降低低密度脂蛋白水平, objectType=article, longId=32745, objectId=a8ae32e4548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8ae32e4548, replyNumber=0, likeNumber=70, createdTime=2014-04-20, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8ae32e4548, moduleTitle=ACC 2014：PCSK9抑制剂显著降低低密度脂蛋白水平, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a8ae32e4548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685553, encodeId=d8f5168555311, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=SHPCS 2013：胰腺癌的分子标志物：整合素（Integrin）α6β4, objectType=article, longId=23281, objectId=22542328165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22542328165, replyNumber=0, likeNumber=75, createdTime=2013-09-01, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22542328165, moduleTitle=SHPCS 2013：胰腺癌的分子标志物：整合素（Integrin）α6β4, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=22542328165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685555, encodeId=02a716855557b, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=SHPCS 2013：胰腺癌的内科治疗策略, objectType=article, longId=23283, objectId=719c2328389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=719c2328389, replyNumber=0, likeNumber=76, createdTime=2014-05-24, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=719c2328389, moduleTitle=SHPCS 2013：胰腺癌的内科治疗策略, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=719c2328389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685552, encodeId=c3c61685552a4, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Nat. Rev. Endocrinol.: PCSK9或为降低LDL胆固醇新靶点, objectType=article, longId=19287, objectId=2b701928efc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b701928efc, replyNumber=0, likeNumber=97, createdTime=2013-06-01, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b701928efc, moduleTitle=Nat. Rev. Endocrinol.: PCSK9或为降低LDL胆固醇新靶点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b701928efc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685557, encodeId=98de168555e49, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JVI：HCMV感染NPCs初步研究获进展, objectType=article, longId=27130, objectId=e8952e130f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8952e130f6, replyNumber=0, likeNumber=75, createdTime=2014-02-04, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8952e130f6, moduleTitle=JVI：HCMV感染NPCs初步研究获进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e8952e130f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685551, encodeId=3f061685551b7, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=LANCET：PCSK单克隆抗体降低家族性高胆固醇血症患者的低密度脂蛋白胆固醇试验, objectType=article, longId=12338, objectId=b7df12338a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7df12338a9, replyNumber=0, likeNumber=71, createdTime=2012-12-14, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7df12338a9, moduleTitle=LANCET：PCSK单克隆抗体降低家族性高胆固醇血症患者的低密度脂蛋白胆固醇试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b7df12338a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PCS

2020-05-29

Tamikia (审核中...)

前往app查看评论内容

#PCS#

郭艺芳：PCSK9单克隆抗体能否撼动他汀霸主地位？

2014-08-26

Tamikia (审核中...)

前往app查看评论内容

#PCS#

SHPCS 2013：胰腺癌的外科治疗——R0切除

2013-12-30

Tamikia (审核中...)

前往app查看评论内容

#PCS#

ACC 2014：PCSK9抑制剂显著降低低密度脂蛋白水平

2014-04-20

Tamikia (审核中...)

前往app查看评论内容

#PCS#

SHPCS 2013：胰腺癌的分子标志物：整合素（Integrin）α6β4

2013-09-01

Tamikia (审核中...)

前往app查看评论内容

#PCS#

SHPCS 2013：胰腺癌的内科治疗策略

2014-05-24

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Nat. Rev. Endocrinol.: PCSK9或为降低LDL胆固醇新靶点

2013-06-01

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JVI：HCMV感染NPCs初步研究获进展

2014-02-04

Tamikia (审核中...)

前往app查看评论内容

#PCS#

LANCET：PCSK单克隆抗体降低家族性高胆固醇血症患者的低密度脂蛋白胆固醇试验

2012-12-14

科室
- - 订阅+
  - 更多科室
工具
服务